2018
DOI: 10.1016/j.biochi.2018.05.023
|View full text |Cite
|
Sign up to set email alerts
|

Cysteine cathepsins as a prospective target for anticancer therapies—current progress and prospects

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
28
0
2

Year Published

2019
2019
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 39 publications
(31 citation statements)
references
References 279 publications
0
28
0
2
Order By: Relevance
“…Normal cells and cancer cells have defense mechanisms to protect against cell death by LMP. The cystatin family is composed of stefins, cystatins, and kininogens, and they are endogenous cysteine cathepsin inhibitors [ 44 ]. In addition, HSP70 modulates lysosome membrane integrity.…”
Section: Discussionmentioning
confidence: 99%
“…Normal cells and cancer cells have defense mechanisms to protect against cell death by LMP. The cystatin family is composed of stefins, cystatins, and kininogens, and they are endogenous cysteine cathepsin inhibitors [ 44 ]. In addition, HSP70 modulates lysosome membrane integrity.…”
Section: Discussionmentioning
confidence: 99%
“…Over the years the central importance of the Cathepsins in disease have been intensely explored, particularly in the context of tumor proliferation, metastasis, invasion, ECM degradation, angiogenesis [13] and inflammation [14]. Consequently, it is with these perspectives in mind that the driving force behind Cathepsin research has broadly diversified with significant progress being made in certain areas of applied research, such as antibody-drug conjugates, diagnostic imaging and their use in targeted drug delivery [14,15].…”
Section: The Cathepsins and Cancermentioning
confidence: 99%
“…Due to their high reactivity and lack of selectivity, E-64 and its cell-permeable derivative E-64d are not applicable to clinical practice. However, E-64 represents the lead compound for the development of new inhibitors with increased selectivity (reviewed in [ 90 , 152 , 153 , 155 ]). As a derivative of E-64, the potent and selective cathepsin B inhibitor CA-074 was synthesized [ 107 ], and its low membrane permeability was improved by methylation of the carboxyl group [ 166 ].…”
Section: Introductionmentioning
confidence: 99%